Tiziana Life Sciences Ltd
TLSA
Get informed when a big investor buys or sells
+ FollowMarket Cap$65.37M
Close$
$0.08
92.7% downside
Current Fair Value
92.7% downsideOvervalued by 92.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $65.37 Million |
|---|---|
| Enterprise Value | $62.34 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.32 |
| Beta | 0.42 |
| Outstanding Shares | 59,467,557 |
Return
| Return on Equity | -58257.69% |
|---|---|
| Return on Assets | -263.54% |
| Return on Invested Capital | -12132.87% |
Valuation & Multiples
| P/E Ratio | -4.1 |
|---|---|
| PEG | -5.28 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.8 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 18.96 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 5, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
June 18, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 40,600▲ 64.37% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.36%▲ 0.31% |
|---|---|
| Total Invested | $3.67M▲ 20.43% |
| Investors Holding | 340% |
ESG Score
No data
About Tiziana Life Sciences Plc
CEO: Shailubhai Kunwar